[HTML][HTML] HMGA2 regulation by miRNAs in cancer: affecting cancer hallmarks and therapy response
M Hashemi, M Rashidi, K Hushmandi… - Pharmacological …, 2023 - Elsevier
High mobility group A 2 (HMGA2) is a protein that modulates the structure of chromatin in the
nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this …
nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this …
HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
M Hashemi, M Rashidi, K Hushmandi… - Pharmacological …, 2023 - pubmed.ncbi.nlm.nih.gov
High mobility group A 2 (HMGA2) is a protein that modulates the structure of chromatin in the
nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this …
nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this …
HMGA2 regulation by miRNAs in cancer: affecting cancer hallmarks and therapy response.
M Hashemi, M Rashidi, K Hushmandi… - Pharmacological …, 2023 - europepmc.org
High mobility group A 2 (HMGA2) is a protein that modulates the structure of chromatin in the
nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this …
nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this …